Dr Neil Love
Host of Oncology Today with Dr Neil Love
Research To Practice
Miami, Florida
Dr Neil Love has hosted 320 Episodes.
-
Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma with Dr Gilles Salles
March 22nd, 2021 | Season 1 | 1 hr 12 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent data on the treatment of diffuse large B-cell lymphoma with Dr Gilles Salles, moderated by Dr Neil Love.
-
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy with Dr Andrew Wei
March 19th, 2021 | Season 1 | 54 mins 15 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent data on the treatment of acute myeloid leukemia not eligible for intensive induction therapy with Dr Andrew Wei, moderated by Dr Neil Love.
-
PARP Inhibitors in Ovarian Cancer with Dr Antonio González-Martín
March 12th, 2021 | Season 1 | 44 mins 41 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the use of PARP inhibitors in ovarian cancer with Dr Antonio González-Martín, moderated by Dr Neil Love.
-
Predictors of Response to Cancer Immunotherapy with Prof Solange Peters
March 12th, 2021 | Season 1 | 1 hr 11 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on predictors of response to cancer immunotherapy with Prof Solange Peters, moderated by Dr Neil Love.
-
Recently Approved Agents in Multiple Myeloma with Dr Joseph Mikhael
March 10th, 2021 | Season 1 | 45 mins 52 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on newly approved agents in multiple myeloma with Dr Joseph Mikhael, moderated by Dr Neil Love.
-
Current and Emerging Strategies for Patients with Non-Small Cell Lung Cancer Harboring an EGFR Exon 20 Insertion Mutation with Dr Zofia Piotrowska
March 8th, 2021 | Season 1 | 1 hr 5 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on new targets in non-small cell lung cancer with Dr Zofia Piotrowska, moderated by Dr Neil Love.
-
Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram
March 3rd, 2021 | Season 1 | 1 hr 5 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on newly approved and emerging therapies for HER2-positive metastatic breast cancer with Dr Mark Pegram, moderated by Dr Neil Love.
-
Current Role of Minimal Residual Disease Assessment in the Management of Multiple Myeloma and Chronic Lymphocytic Leukemia with Drs Shaji Kumar and Philip Thompson
March 1st, 2021 | Season 1 | 1 hr 17 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring discussions on the role of minimal residual disease evaluation in the management of multiple myeloma and chronic lymphocytic leukemia with Drs Shaji Kumar and Philip Thompson, moderated by Dr Neil Love.
-
New Targets in Non-Small Cell Lung Cancer with Dr Justin Gainor
February 26th, 2021 | Season 1 | 45 mins 48 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on new targets in non-small cell lung cancer with Dr Justin Gainor, moderated by Dr Neil Love.
-
ER-Positive Metastatic Breast Cancer with Dr Erika Hamilton
February 24th, 2021 | Season 1 | 43 mins 9 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the selection and sequencing of available and emerging therapies for ER-positive metastatic breast cancer with Dr Erika Hamilton, moderated by Dr Neil Love.
-
Key Presentations on Chronic Lymphocytic Leukemia and Follicular Lymphoma from the 2020 ASH Annual Meeting with Dr Ann LaCasce
February 19th, 2021 | Season 1 | 1 hr 50 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring discussion on important data sets in chronic lymphocytic leukemia and follicular lymphoma from the 2020 ASH Annual Meeting with Dr Ann LaCasce, moderated by Dr Neil Love.
-
Current and Future Treatment Strategies for Advanced Ovarian Cancer with Dr Kathleen Moore
February 19th, 2021 | Season 1 | 1 hr 6 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a presentation and discussion of recent research on the role of PARP inhibitors and other treatment strategies in the management of advanced ovarian cancer with Dr Kathleen Moore, moderated by Dr Neil Love.
-
Front-Line Treatment of Chronic Lymphocytic Leukemia with Dr Steven Coutre
February 16th, 2021 | Season 1 | 1 hr 17 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the first-line treatment of chronic lymphocytic leukemia with Dr Steven Coutre, moderated by Dr Neil Love.
-
Key Presentations on Myeloproliferative Neoplasms from the 2020 ASH Annual Meeting with Dr Aaron T Gerds
February 12th, 2021 | Season 1 | 1 hr 10 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on important data sets on myeloproliferative neoplasms from the 2020 ASH Annual Meeting with Dr Aaron Gerds, moderated by Dr Neil Love.
-
Newly Approved Agents in the Management of Urothelial Bladder Carcinoma with Dr Matthew Galsky
February 5th, 2021 | Season 1 | 40 mins 19 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recently approved agents in the treatment of urothelial bladder carcinoma with Dr Matthew Galsky, moderated by Dr Neil Love.
-
Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations with Dr Corey Langer
January 29th, 2021 | 39 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
The second issue of this program on the role of immune checkpoint inhibitors in the treatment of metastatic NSCLC without targetable alterations features a discussion with Dr Corey Langer, moderated by Dr Neil Love.